Premium
Toxic epidermal necrolysis and co‐existent SARS‐CoV‐2 (COVID‐19) treated with intravenous immunoglobulin: ‘ Killing 2 birds with one stone ’
Author(s) -
Saha M.,
D’Cruz A.,
Paul N.,
Healy R.,
Collins D.,
Charles D.A.,
Sahu S.,
Fonia A.
Publication year - 2021
Publication title -
journal of the european academy of dermatology and venereology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.655
H-Index - 107
eISSN - 1468-3083
pISSN - 0926-9959
DOI - 10.1111/jdv.16887
Subject(s) - medicine , toxic epidermal necrolysis , covid-19 , intravenous immunoglobulin therapy , antibody , virology , immunoglobulin g , betacoronavirus , dermatology , immunology , outbreak , disease , infectious disease (medical specialty)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom